MeiraGTx Holdings (MGTX) Work In Process (2022 - 2023)
MeiraGTx Holdings (MGTX) reported Work In Process of $732000.0 for Q3 2023, down 1.35% quarter-over-quarter from $742000.0 in Q4 2022.
MeiraGTx Holdings (MGTX) Work In Process (2022 - 2023) Analysis & Trends
MeiraGTx Holdings has reported Work In Process for 2 years, with the latest figure at $732000.0 in Q3 2023.
- For the quarter ending Q3 2023, Work In Process changed N/A year-over-year to $732000.0; the trailing twelve-month figure through Sep 2023 stood at $732000.0 (changed N/A YoY), and the FY2022 full-year result was $742000.0, changed N/A from the prior year.
- Work In Process for Q3 2023 stood at $732000.0, down from $742000.0 in the prior quarter.
- The five-year high for Work In Process was $742000.0 in Q4 2022, with the low at $732000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 732,000.00 |
| Dec 31, 2022 | 742,000.00 |